Latest Biosimilar Stories
Today, NCPDP addressed the FDA, CDER and ODAC meeting that met to review and make a recommendation on what may be the first biosimilar to receive FDA approval in the U.S., and potentially develop
New report from Kantar Health shows opportunities for biosimilars are high in oncology, low in rheumatoid arthritis in China. Shanghai, China (PRWEB) December
Biosimilar stakeholders urge the FDA to pass final regulations related to the drugs at a recent conference on biosimilars, reports Atlantic Information Services’ Specialty Pharmacy News in its
Believed to be the First Company to Have a Biosimilar Filing Accepted for Review of Amgen's Neulasta® TORONTO, Dec.
The company leverages its keen understanding of protein purification to achieve the highest purification standards and product quality LONDON, Dec.
BIRMINGHAM, Ala. and BATON ROUGE, La. and RALEIGH, N.C. and RESEARCH TRIANGLE PARK, N.C., Dec.
- A young chicken: also used as a pet name for children.